(Press-News.org) Shingles vaccine is associated with reduction in both postherpetic neuralgia and herpes zoster, but uptake in the US is low
A vaccine to prevent shingles may reduce by half the occurrence of this painful skin and nerve infection in older people (aged over 65 years) and may also reduce the rate of a painful complication of shingles, post-herpetic neuralgia, but has a very low uptake (only 4%) in older adults in the United States, according to a study by UK and US researchers published in this week's PLOS Medicine.
The researchers, led by Sinéad Langan from the London School of Hygiene and Tropical Medicine, reached these conclusions by examining the records of 766,330 Medicare beneficiaries* aged 65 years or more between 2007 and 2009.
They found that shingles vaccine uptake was extremely low—only 3.9% of participants were vaccinated—but was particularly low among black people (0.3%) and among people with a low income (0.6%).
Over the study period, almost 13,000 participants developed shingles and the vaccine reduced the rate of shingles by 48% (that is, approximately half as many vaccinated individuals developed shingles as those who were not vaccinated). However, the vaccine was less effective in older adults with impaired immune systems. The authors also found that vaccine effectiveness against post-herpetic neuralgia was 59%.
The authors say: "Herpes zoster vaccination was associated with a significant reduction in incident herpes zoster and [post-herpetic neuralgia] in routine clinical use."
They continue: "Despite strong evidence supporting its effectiveness, clinical use remains disappointingly low with particularly low vaccination rates in particular patient groups."
The authors add: " The findings are relevant beyond US medical practice, being of major importance to the many countries, including the UK, that are actively considering introducing the zoster vaccine into routine practice in the near future."
###
* Medicare is a US government health insurance scheme that mainly helps to pay the health-care costs of people aged 65 or older.
Funding: This research was funded by an NIHR Clinician Scientist award from the National Institute for Health Research, UK Department of Health, awarded to SML. The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the UK Department of Health.
Competing Interests: LS has undertaken consultancy for GlaxoSmithKline. DJM is on separate data safety monitoring boards for Abbott and Astellas. The authors declare no other conflicts of interest.
Citation: Langan SM, Smeeth L, Margolis DJ, Thomas SL (2013) Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study. PLoS Med 10(4): e1001420. doi:10.1371/journal.pmed.1001420
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001420
Contact:
Dr Sinéad Langan
NIHR Clinician Scientist
London School of Hygiene and Tropical Medicine
Epidemiology and Population Health
Keppel Street
London, WC1E 7HT
UNITED KINGDOM
0044 207 9272680
sinead.langan@lshtm.ac.uk END
Shingles vaccine is associated with reduction in both postherpetic neuralgia and herpes zoster
2013-04-10
ELSE PRESS RELEASES FROM THIS DATE:
New guidelines for writing abstracts will help authors summarise their research
2013-04-10
New guidelines for writing abstracts will help authors summarise their research
A new extension to the PRISMA guideline on reporting systemic reviews and meta-analyses (types of studies that analyse information from many studies) will help authors to give a more robust summary (abstract) of their study and is detailed by an international group of researchers in this week's PLOS Medicine.
These guidelines for abstracts of systemic reviews and meta-analyses are important, as the abstract is the most frequently read part of most papers and these types of studies are ...
Genetic biomarker may help identify neuroblastomas vulnerable to novel class of drugs
2013-04-10
An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor, a difficult-to-treat, early childhood cancer, is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors, Dana-Farber/Children's Hospital Cancer Center scientists will report at the annual meeting of the American Association for Cancer Research in Washington, April 6-10.
The findings (abstract 4622) will be discussed in a minisymposium on Tuesday, April 9, 3:50 - 4:05 p.m., ET, in Room 147, in the Washington Convention Center. The work was published in ...
Alzheimer gene ABCA7 significantly increases late-onset risk among African Americans
2013-04-10
PHILADELPHIA - A variation in the gene ABCA7 causes a twofold increase in the risk of late onset Alzheimer disease among African Americans, according to a meta-analysis by a team of researchers including experts from the Perelman School of Medicine at the University of Pennsylvania. This is the largest analysis to date to determine genetic risk associated with late-onset Alzheimer disease (LOAD) specifically in African American individuals. The study appears in the April 10 issue of JAMA, a genomics theme issue.
The Alzheimer Disease Genetics Consortium (ADGC) – led ...
Modest population-wide weight loss could result in reductions in Type 2 diabetes and cardio disease
2013-04-10
A paper published today on bmj.com suggests a strong association between population-wide weight change and risk of death from type 2 diabetes and cardiovascular disease.
Variation in the prevalence of type 2 diabetes across populations can be largely explained by obesity. However, it is unclear as to what extent weight loss would lower cardiovascular disease prevalence.
Whole population trends in food consumption and transportation policies linked to physical activity could reduce the burden of type 2 diabetes and cardiovascular disease at the population level.
Following ...
Neutrons help explain ozone poisoning and links to thousands of premature deaths each year
2013-04-10
A research team from Birkbeck, University of London, Royal Holloway University and Uppsala University in Sweden, have helped explain how ozone causes severe respiratory problems and thousands of cases of premature death each year by attacking the fatty lining of our lungs.
In a study published in Langmuir, the team used neutrons from the Institut Laue-Langevin in Grenoble and the UK's ISIS Neutron Source to observe how even a relatively low dose of ozone attacks lipid molecules that line the lung's surface. The presence of the lipid molecules is crucial for the exchange ...
TGen-Scottsdale Healthcare clinical trial results for BIND-014 presented at AACR 2013
2013-04-10
WASHINGTON, D.C. — April 9, 2013 — The nanoparticle drug BIND-014 is effective against multiple solid tumors, according to results generated by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, and presented today at the American Association for Cancer Research (AACR) Annual Meeting 2013.
Data for the study was generated at the Virginia G. Piper Cancer Center Clinical Trials, a partnership of TGen and Scottsdale Healthcare.
Dr. Daniel Von Hoff, TGen Physician-In-Chief and Chief Scientific Officer of Scottsdale Healthcare's Clinical Research ...
TGen-Scottsdale Healthcare clinical trial finds new class of cancer drugs safe and effective
2013-04-10
SCOTTSDALE, Ariz. — April 9, 2013 — The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).
Early results from the phase I, first in-human study of an RNA interface (RNAi) drug were announced during the American Association for Cancer Research (AACR) Annual Meeting 2013, April 6-10, in Washington, D.C. The drug, TKM-080301 (also known as TKM-PLK1) is being developed by Tekmira Pharmaceuticals Corporation.
The ...
The genetics of life and death in an evolutionary arms-race
2013-04-10
Scientists at The University of Manchester have found evidence of the genetic basis of the evolutionary arms-race between parasitoids and their aphid hosts.
The researchers studied the reaction of aphids when a parasitic wasp with genetic variation laid eggs in them. They found that different genotypes of the wasp affected where the aphids went to die, including whether they left the plant host entirely. The team also found an example of the emergence of a shared phenotype that was partly wasp and partly aphid.
Dr Mouhammad Shadi Khudr, a visiting scientist at the Faculty ...
Moa's ark
2013-04-10
Some of the largest female birds in the world were almost twice as big as their male mates. Research carried out by the Zoological Society of London (ZSL) shows that this amazing size difference in giant moa was not due to any specific environmental factors, but evolved simply as a result of scaling-up of smaller differences in male and female body size shown by their smaller-bodied ancestors.
The paper is published today (10th April) in Proceedings of the Royal Society B.
In an environment lacking large mammals, New Zealand's giant moa (Dinornis) evolved to be one ...
Not slippery when wet: Geckos adhere to surfaces submerged underwater
2013-04-10
Geckos are known for their sticky adhesive toes that allow them to stick to, climb on, and run along surfaces in any orientation--even upside down! But until recently, it was not well understood how geckos kept their sticking ability even on wet surfaces, as are common in the tropical regions in which most geckos live. A 2012 study in which geckos slipped on wet glass perplexed scientists trying to unlock the key to gecko adhesion in climates with plentiful rain and moisture.
A study supported by the National Science Foundation and published in the Proceedings of the ...